Westminster, MD, United States of America

Willem Folkerts

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Willem Folkerts in Dynamic Surveillance of Medication

Introduction

Willem Folkerts is an accomplished inventor based in Westminster, MD (US). He has made significant contributions to the field of healthcare technology, particularly in the area of medication surveillance and treatment regimen selection. With a total of 2 patents, Folkerts is recognized for his innovative approaches to improving patient care.

Latest Patents

Folkerts' latest patents focus on systems and methods for dynamic surveillance of medication and antimicrobial resistance trends. These patents provide a framework for selecting treatment regimens tailored to individual patients. The first patent outlines a system that utilizes a first data store containing patient records and a second data store with efficacy rates of various treatment regimens. By identifying a patient's specific infection, the system generates a second set of patient records that are enhanced with efficacy rates. This dynamic model allows for a likelihood estimation of the appropriateness of the prescribed treatment regimen.

Career Highlights

Willem Folkerts is currently employed at Becton Dickinson and Company Limited, where he continues to develop innovative solutions in healthcare. His work is instrumental in addressing the challenges of antimicrobial resistance and improving treatment outcomes for patients.

Collaborations

Folkerts collaborates with notable colleagues, including Vikas Gupta and John Murray, who contribute to the advancement of their shared goals in healthcare innovation.

Conclusion

Willem Folkerts exemplifies the spirit of innovation in the healthcare sector through his patents and collaborative efforts. His work significantly impacts the way treatment regimens are selected and monitored, ultimately enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…